# CuePath Innovation

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/cuepath-innovation

- Industry: Medical Devices & Equipment
- Headquarters: Vancouver, Canada
- Website: www.cuepath.com
- Total disclosed funding: $0.1M
- Latest round: Seed (Jan 26, 2017)
- Investors on record: 3

## About

CuePath Innovation Inc. is a technology firm focused on enhancing medication adherence through innovative monitoring solutions. Their flagship product, CuePack™, leverages advanced technology to track medication intake in real-time.Founded in 2015 and headquartered in Vancouver, Canada, CuePath Innovation Inc. specializes in medication adherence monitoring technologies. The company has engaged in six total deals, with its most recent funding round occurring on June 1, 2021, during which it raised USD 1.80 mn in a Seed round led by Canada Innovation Acceleration Investment, E-Fund, and Genome British Columbia. Ken Piaggio serves as the CEO.CuePath Innovation specializes in advanced medication adherence monitoring technologies, primarily through its flagship product, CuePack™. This solution uses smart stickers on standard blister packs to enable real-time tracking of medication intake. The CuePack™ integrates with clinical trial management software such as REDCap, facilitating precise data collection and analysis for clinical researchers involved in large-scale drug trials. CuePath's technologies are suitable for studies with controlled substances and high-value medications, addressing challenges like participant retention and adherence reporting. Current users include clinical research organizations and academic institutions focused on mental health and substance use disorder research, with applications in the ASCME trial for methamphetamine use disorder treatment in Canada. The company primarily operates in North America, targeting the mental health and substance use clinical trial sectors.CuePath Innovation generates revenue through partnerships with clinical research organizations and academic institutions that utilize its CuePack™ technology in trials. The business model focuses on B2B transactions where CROs and researchers license the CuePack™ system for their study duration. Engagements typically involve subscription-based agreements, allowing clients access to the technology and support services essential for effective medication adherence monitoring. Specific pricing structures are customized to each study's needs, ensuring comprehensive data integration and analysis capabilities, enhancing visibility into participant compliance and facilitating streamlined data management during clinical research.With the recent funding from new investor WUTIF Capital (VCC) Inc., CuePath Innovation Inc. plans to expand its product offerings and explore new markets. The company is developing upcoming features for the CuePack™, although specific release dates have not been disclosed. Additionally, CuePath aims to penetrate international markets, focusing on Europe and Asia by the end of 2023. The funds raised will be pivotal in supporting these initiatives, enhancing product development, and facilitating market entry.

## Funding rounds

- Seed, Jan 26, 2017, $0.1M — Techstars, Vancouver Angel Forum
- Seed, Mar 1, 2016 — Right Side Capital Management

## Investors

- Right Side Capital Management (https://capitalatlas.ai/funds/right-side-capital-management) — Seed
- Techstars (https://capitalatlas.ai/funds/techstars) — Seed
- Vancouver Angel Forum (https://capitalatlas.ai/funds/vancouver-angel-forum) — Seed